A bogus vet who pleaded guilty to a number animal cruelty and fraud offences is being sought by Humberside Police after he failed to appear at court for sentencing.
Jayson Paul Wells (pictured right), 30, of Driffield in the East Riding of Yorkshire, is wanted by detectives in Grimsby after he failed to appear at Grimsby Crown Court.
The RCVS assisted Humberside Police with its original investigation and is publicising its appeal to help locate Mr Wells. Police believe that he may be trading as a herdsman in Nottingham or Cornwall and are keen to establish whether he is currently in either location.
Mr Wells was arrested on 2 October 2013 and charged with the following offences:
Mr Wells pleaded guilty to all offences.
Anyone who is aware of his whereabouts is asked to call Humberside Police on 101 or call Crimestoppers anonymously on 0800 555 111.
This year’s Protect and Prevent campaign urged rabbit owners to get their rabbits vaccinated, following the continued outbreak of rabbit viral haemorrhagic disease (RVHD2). Veterinary practices were also urged to make sure they were stocking the necessary vaccines to protect rabbits against RVHD2, RVHD and myxomatosis.
The company says that over 5000 campaign packs were downloaded from the Rabbit Awareness Week website and sales of RVHD2 vaccines in the veterinary sector in June 2019 were 55% up on June 2018.
Peter Lancaster, Marketing Manager at Burgess Pet Care said: "We would like to say a huge thank you to the RAW partners, veterinary practices, rescue centres, pet shop retailers and, of course, rabbit owners, for their continued support in helping us to improve the health and wellbeing of rabbits."
Dr Richard Saunders BVSc DZooMed MRCVS, veterinary advisor to RWAF said: "We heard lots of heart-breaking stories from owners and vets alike about rabbits, sometimes whole groups of rabbits, which had not been vaccinated. None of those people realised just how widespread the RVHD2 is, and how easy it is to pick it up. We will continue to campaign and share our message that it is very much better late than never to vaccinate rabbits against all three killer diseases of rabbits: myxomatosis, Rabbit Viral Haemorrhagic Disease 1 and 2."
PDSA Vet Nurse, Kristiana Shirley, said: "Rabbit Awareness Week provided us with a great opportunity to engage with rabbit owners and raise awareness of the key preventative healthcare our bunnies so vitally need.
"During Rabbit Awareness Week in June, we saw a significant increase in the number of vaccines given when compared to previous months, and an increase in our rabbit MOTs too, which we hope is just the start of a trend which sees more owners protecting their rabbits from preventable, fatal diseases."
For more information on Rabbit Awareness Week, including free access to rabbit CPD, visit www.rabbitawarenessweek.co.uk
Claire was presented with the award at a black tie event in Manchester yesterday.
She said: Our local community is massively important to myself and my practice – we have been going 50 years this year so it’s a big year for us this year so to get this award on this anniversary means so much, especially for my husband’s father who started the practice and sadly passed away a number of years ago so I just wish he’d been here to see it.”
The other winners were:
Petplan’s Sales and Marketing Director, Bella von Mesterhazy said: “All of the night’s winners are so deserving of the accolade, thanks to their true commitment to their profession, and like all those who sent in nominations, Petplan is incredibly grateful for the outstanding services provided by not only our winners, but veterinary professionals around the country.”
Fluboral controls gastro-intestinal nematodes including Ascaridia galli (adult stages), Heterakis gallinarum (adult stages) and Capillaria spp. (adult stages) in chickens and Ascaris suum (adult and L4 intestinal stages) in pigs.
Dechra says Fluboral’s formula allows it to mix in drinking water quickly and easily with five seconds of stirring.
Fluboral has a guaranteed 24-hour stability without sedimentation of the suspension after dilution in drinking water and Dechra says there is no risk of inhomogeneous mixing.
Johnny Wells West, key account manager – pig and poultry at Dechra, said: “Fluboral is a welcome addition to our Solustab range of water-soluble products, providing effortless and efficient parasite control in drinking water to enable farmers and producers to start medication quickly and cost-effectively, as and when needed.”
https://www.dechra.co.uk/products/livestock/prescription/fluboral#Fluboral.
The BVA has partnered with Closer Still Media, the impresarios behind the London Vet Show, to organise the event. They say it will cater for 1,500 veterinary professionals and provide high-value, low-cost, practical clinical and non-clinical CPD, big issue debates, and showcase key veterinary suppliers and vendors in the exhibition in a vibrant central location.
BVA President Daniella Dos Santos said: "I’m delighted to announce the launch of BVA Live. It’s an opportunity for BVA to return to hosting our own standalone conference for the first time since BVA Congress became part of the London Vet Show in 2013. The new conference will enable the veterinary community to come together, outside of London, to develop and thrive through a programme of excellent CPD, delivered by world class speakers.
"For me the most important element of BVA Live is bringing the veterinary profession together to tackle the big issues we face and providing an opportunity to engage with BVA Officers, volunteers and staff in one central venue. By hosting the conference at the NEC, Birmingham, with its excellent direct road, rail and air links it means that we can provide a greater regional offering to the veterinary profession."
It remains to be seen what impact this new conference will have on BSAVA Congress, which for many years was pretty much the only gig in town. Then, with the London Vet Show snapping at its heels, it announced it would move north from Birmingham to Manchester from 2021. Hardly will the dust have settled, than BVA and CloserStill are filling the void. At this rate, BSAVA Congress will probably have to move to the Hebrides by 2025.
It looks like there are a lot of dice being rolled here. Will more vets want to meet in Manchester than Birmingham? Will any of us be meeting next year, or will coronavirus continue to limit gatherings in 2021?
For more information and to register your interest in attending, visit bvalive.vetshow.com
Last year, the company had more than 37,000 entries from pet owners and the veterinary community for the five award categories:
The winners will be announced later this year and will recognise the remarkable work carried out by some of the best veterinary professionals in the country.
James Barnes, Head of Sales & Partnerships at Petplan (pictured right), said: “Now more than ever it’s important to recognise the lengths the veterinary community goes to in looking after our pets. Every year we’re astounded by the quality and quantity of nominations which are a real testament to the hard work of all of those involved at practices who care for animals and clients all year round.
"The awards are a perfect opportunity for you to showcase your practice and your colleagues. If you haven’t already I’d invite you to nominate someone today.”
Nominate a colleague or your practice at www.petplanvet.co.uk/vetawards.
Intervet/Schering-Plough Animal Health has announced the launch of PORCILIS AR-T DF, an inactivated vaccine against progressive atrophic rhinitis in piglets with a new adjuvant which the company says is associated with fewer injection site reactions.
PORCILIS AR-T DF uses DILUVAC FORTE (DF), an aqueous vitamin E-based adjuvant and will replace PORCILIS AR-T, a similar vaccine containing an oil-based adjuvant. The newly formulated vaccine is approved to reduce the clinical signs of progressive atrophic rhinitis in their offspring. Progressive atrophic rhinitis is caused by a toxin from the bacteria Pasteurella multocida affecting bone-forming cells in the snout of the young piglet.
Marc Dickie, Senior Director, Global Swine Business Unit at Intervet/Schering-Plough Animal Health said: "The innovative PORCILIS AR-T DF vaccine combines the proven efficacy of the current PORCILIS AR-T with an improved safety profile and convenience for the veterinarian that is offered by the aqueous DILUVAC FORTE adjuvant. The new vaccine also demonstrates the commitment of our company to continuously improve our vaccines, thereby offering value-added benefits to our customers."
Currently used by more than 200 practices and 50 universities around the world, the Equinosis Q is a diagnostic tool that can further aid the subjective lameness evaluation on all types of horses and ponies examined in the field or in hospital settings.
Christina Frigast, MRCVS, Eickemeyer Product Development Manager said: "The inertial sensors sample 20x faster than the human eye making the Equinosis Q a valuable tool to the veterinarian in the evaluation of subtle and multiple limb lameness.
"It does not interfere with the routine lameness examination as trot up on straight line, lunging and ridden evaluations can be performed on both hard and soft surfaces.
"Data is wirelessly streamed to a tablet PC and compiled into a reader-friendly report displaying the timing and severity of lameness. The effectiveness of diagnostic blocks can also be assessed with the Equinosis Q, providing the veterinarian with a percentage of improvement. In addition, comparison reports can be used to monitor rehabilitation progress."
Contact Eickemeyer to book a free demo, or for further information, visit: https://www.eickemeyer.co.uk/Diagnostics-and-Education/Anatomy-Models/Lameness-Locator-vet.html?listtype=search&searchparam=lameness
watch?v=MS6UXQSq6q0
The new series comprises six online discussions taking place over the course of the spring, covering everything from diversity to creativity to identity.
The upcoming programme of events is as follows:
Tuesday 1st March 2022 7pm to 8pm: Celebrating diversityChaired by Gurpreet Gill, RCVS Leadership & Inclusion Manager. Panel members Lacey Pitcher RVN, Dr Olivia Anderson-Nathan MRCVS and Samantha Payne RVN will be talking about what celebrating diversity means to people, exploring how this links to mental health, and sharing their thoughts on why – and how – the professions should be working towards greater inclusivity, both in and out of the workplace.
Monday 21st March 2022 7pm to 8pm: The joy of creativityThis discussion will look at why creativity is so important for people’s lives and how it can be used to support mental health and wellbeing with a panel comprising Dr Silvia Janksa MRCVS and Olivia Oginska MRCVS.
Tuesday 5th April 2022 7pm to 8pm: Overcoming self-doubt and stressing outThis discussion will consider the main causes of stress in the veterinary workforce and how this may have shifted throughout the pandemic. The discussion will encompass coping strategies, the ways in which stress can be channelled in a more constructive way, and overcoming feelings of self-doubt.
Thursday 21st April 2022 7pm to 8pm: Identity – who am I away from work?This discussion will consider to what extent veterinary professionals should let their careers define them, the importance of understanding oneself in and out of a work setting, and how people can learn to value, accept, and appreciate their whole selves.
Tuesday 3rd May 2022 7pm to 8pm: Saying goodbye…letting go and learning to growThis discussion will consider how best to cope with the various types of loss that may be encountered in an individual’s professional and personal life, and how to learn, adapt and grow from these losses.
Thursday 12th May 2022 7pm to 8pm: Tackling loneliness in a hyperconnected worldThis Campfire Chat will discuss why meaningful connection and having a sense of belonging matters, and how individuals and communities can tackle loneliness in a hyperconnected world.
Angharad Belcher, Director of the Mind Matters Initiative, said: “We all lead busy professional and personal lives and sometimes it means that self-care, which includes talking to others about how we’re feeling and about issues that we find important to us, can fall by the wayside.
“Our Campfire Chats offer a perfect opportunity – and excuse – to take a bit of time out of your schedule to engage in a structured but informal discussion about all manner of subjects, expertly led by a chair and panel with experience, lived and otherwise, on the topic being talked about.
“These events are for the whole veterinary team, we keep the sessions very informal, and there is also the opportunity to share or ask questions of the panel.”
To sign up for the first session, visit https://bit.ly/3GnQK0G.
For further information about the events contact Abi Hanson, Mind Matters Initiative Officer, on a.hanson@rcvs.org.uk
A quick poll carried out by Michael Woodhouse amongst the members of VetSurgeon suggests that the majority of UK veterinary surgeons do not brush their own dog's teeth.
98 members took part in the survey, as follows:
Petplan has announced that nominations for its 2015 Veterinary Awards will open on 1st September 2014.
The awards, which are designed to recognise members of the veterinary profession who have gone 'above and beyond' in their daily roles, will be presented on 9th April 2015.
Petplan's Acting Head of Marketing, Ingrid Wakefield said: "At Petplan, we hear from our customers every day about the exceptional care veterinary staff have given to their pets. The Veterinary Awards provide an opportunity for Petplan to show their support for members of the veterinary profession who go beyond the call of duty in their role, and for pet owners across the UK to say thank you to the veterinary staff who have helped them and their pets."
Last year Petplan received more than 12,000 nominations, with every nominee receiving a certificate of recognition for their hard work.
Nominations can be made at www.petplan.co.uk/vetawards, from the start of September.
Researchers say that whilst widely discussed, many in the profession may not be aware that prevalence of the disease has been steadily increasing across all regions of the UK.
Since November 2012, 177 cases have been reported, with more than 90% between November and May. However, the cause of CRGV, which often presents as ulcerations to the dog’s skin and can lead to acute kidney injury (AKI) and potentially death, remains unknown.
Practices are being now asked to report suspect cases in a bid to gain vital insight into the disease and what may be causing it.
David Walker BVetMed (Hons) DipACVIM DipECVIM-CA from Anderson Moores (pictured right) is helping lead the research: "CRGV is a disease that impacts lots of breeds across the UK. Reports show there is seasonality to the disease and therefore an environmental cause is a possible component in its development.
"This research is part of the puzzle and will hopefully help to guide further work on this disease. By collecting more information on confirmed cases, such as walking habits and diet, we hope to build more understanding in order to better protect pets and inform treatment decisions."
To gather this information, Anderson Moores is asking practices to share a 10-minute online survey with the owners of dogs in which CRGV has been confirmed, as well as some control dogs following criteria provided with the survey link.
David said: "Many pet owners are aware of this disease and are concerned for their pets; if they are asked to help they are usually happy to do so. By offering a direct link to the survey, very little of the veterinarian’s time is needed to collate the information."
If you have a suspected case of CRGV, contact Anderson Moores on 01962 767920 or email medicine@andersonmoores.com
If the pet does not survive, then histopathologic assessment of tissue will be performed free of charge to confirm the diagnosis.
In confirmed cases the veterinary surgeon will be sent a link to a 10-minute survey to be completed by the owner.
Along with encouraging the owner of the confirmed case to take part, four unaffected control cases from the same clinic, on the same day, will also need to be recruited.
When a set of five qualifying surveys (one confirmed case and 4 control cases) are provided, practices can claim an Amazon Echo Dot, provided by Bayer, as a thank you for helping with the research.
One £20,000 grant will be awarded each year for five years, starting in 2019 (making a £100,000 total by 2023) to fund research that focuses on mental health and wellbeing within the veterinary professions, including areas such as prevention, diagnosis, intervention and treatment.
Applications are welcome from individuals at all stages of their research careers, including those who have not previously been published, with research proposals relating to any aspect of mental health or wellbeing in the veterinary professions. Researchers must be affiliated with a university, and ethical approval must be in place.
RCVS CEO, Lizzie Lockett, said: "Sarah Brown was a talented veterinary surgeon who was passionate about her profession. She was respected and loved by so many people and worked hard to support others. So it is fitting that, with the blessing of Sarah’s family, we are able to launch this grant in her memory. It’s only by improving the veterinary mental health evidence base that we will be able to hone the interventions and support that is available to members of the veterinary team."
Applicants should send their research proposal, along with a CV and short biography for all lead researchers, to Lisa Quigley, Mind Matters Initiative Manager, by 5pm on Friday 31 May 2019.
Each proposal should be a maximum of 3,000 words and should include aims, methods, ethical considerations, proposed timelines, and a bibliography. Any academic literature referred to within the proposal should be accurately referenced. The winner of the grant will be decided in June 2019, with the winner then receiving their award at Royal College Day in London on Friday 12 July 2019.
The recipient of the Sarah Brown Mental Health Research Grant for 2019 will be invited to present their research findings at the biennial Mind Matters Initiative Research Symposium in 2021.
Applications are particularly welcomed from those at an early stage in their research career. Guidance on how to prepare a research proposal is available at: https://esrc.ukri.org/funding/guidance-for-applicants/how-to-write-a-good-research-grant-proposal
Kate said: "In recent days we have watched the unfolding events in Ukraine in horror, shock and with tremendous sadness.
"We are determined to offer as much help and support as we can to our Ukrainian veterinary colleagues fleeing this crisis and seeking refuge in the UK.
To that end, the College offers a financial support scheme for refugees which is immediately available for Ukrainian veterinary surgeons with refugee status.
The scheme enables refugee vets to take the RCVS Statutory Examination for free, offers financial support to attend exams, free access to the RCVS library and free membership of BSAVA, BVA, BEVA, BCVA and VMG.
In addition, whilst Russian-based business interests comprise less than 0.1% of the College's investment portfolio, it has instructed its fund managers to get rid of all Russian investments at the very earliest opportunity.
Meanwhile, veterinary dentist Bob Partridge has donated a day's takings from his Harrogate-based, Specialist-led small animal dental referral practice, VetDentist, to the British Red Cross Ukraine.
He said: "I got home late and exhausted, turned on the news, and knew that my “tough day” was as nothing compared to the troubles, the fear and the pain experienced by the people of Ukraine."
Other members of Bob's team followed suit, as did the team at Training-Progress, and they hope others will do the same.
Bob said: "Please put your money where your mouth (or keyboard) is!"
https://donate.redcross.org.uk/appeal/ukraine-crisis-appeal
Photo: CC BY-SA 2.0 Aleksej Leonov
CEVA Animal Health has launched Marbokem, a Marbofloxacin-based antimicrobial for the treatment of respiratory disease in cattle which offers the advantages of a one-shot protocol and a shock-resistant vial.
Marbokem is used for the treatment of respiratory infections caused by sensitive strains of Pasteurella multocida, Mannheimia haemolytica and Histophilus somni. CEVA says Marbofloxacin's efficacy has been proven in terms of re-treatment rate, success, speed of action and MICs in comparison with many frequently used quinolones and macrolides. (1,2,3,4)
According to CEVA, Marbokem's one shot protocol means it's quick and economical to use, while its presentation in an ergonomic CLAS vial makes for light and shock-resistant handling, resulting in fewer breakages and reduced costs. The company says Marbokem is also very competitively priced.
For further product information, please contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at http://www.ceva.uk.com/
1 Grandemange, E., Fournel, S., Woerhle, F. (2009) Field evaluation of the efficacy of 2 antibiotics in treating bovine respiratory infections. Poster, Journées Nationales des GTV, Nantes, France. 2. Grobbel, M., Lübke-Becker, A., Wieler, L., Froyman R., Friederichs, S., Filios, S. (2007) Comparative quantification of the in-vitro activity of veterinary fluoroquinolones. Veterinary microbiology 124 (73-81). 3. Roy, O., Pillet, F., Heurtin-Vallé, A., Frontczak, N. (2008) Comparative field clinical efficacy of a single intramuscular injection of marbofloxacin in the treatment of bovine respiratory disease. Poster, World Buiatrics Congress, Budapest, Hungary.4. Wu, C. (2004) Determination of minimum inhibitory concentrations of danofloxacin and other commonly used cattle antimicrobial agents against Mycoplasma bovis isolated from cattle with clinical disease. Le médecin vétérinaire du Québec. 34 (1-2).
The RCVS is holding a session at the London Vet Show on Saturday 23rd October from 8:30am-9:30am to provide guidance and advice concerning the work your nursing team does in practice.
As the RCVS says, the recent Panorama programme "It shouldn't happen at a vets'" was a stark reminder of the importance of ensuring that all practice staff are working within the appropriate legal framework.
The session will answer such questions as:
Because of the early start, the RCVS is providing breakfast from 8:15am, though I wouldn't get your hopes up for eggs benedict and freshly smoked Loch Fyne kippers.
The RCVS says the session will be relevant for all members of the practice team, but that if you can't make the session, they will be on hand to discuss VN legislation on stand M26.
The RSPCA is asking veterinary surgeons to take part in a new survey which aims to build a true picture of the scale of the problem of illegally imported puppies being brought into the UK.
Amongst other things, the survey asks what you consider to be the greatest concerns regarding the poor breeding, dealing and illegal import of puppies and what you think can be done to tackle these and the associated problems.
You can take part in the survey here: www.surveymonkey.com/s/QQNBVFV
James Yeates, Chief Veterinary Officer, said: "RSPCA intelligence suggests that there is a growing illegal trade in puppies from other EU countries and is causing serious health and welfare problems. In many cases puppies are dying or becoming seriously ill. Risk factors appear to include being taken from their mothers too early, not being vaccinated and having to endure long journeys in poor conditions.
"However, it's very difficult to get a full view on the scale of the problem as many cases never get reported to the RSPCA. Vets are likely to be the first port of call when a puppy bought by an unsuspecting buyer becomes sick and may be faced with many of these cases - if sadly not all.
"We're interested in hearing from vets to get their evidence from practice and to hear their ideas about how we can tackle the lucrative illegal trade in puppies."
Zoetis has announced that PropoFlo Plus is now back in stock following a huge surge in demand caused by supply issues with a competitor propofol.
Licensed for use in dogs and cats, PropoFlo Plus is an anaesthetic injection for the induction and maintenance of general anaesthesia for up to 20 minutes. It is used for dental treatment, biopsies, radiographs, mass removals and endoscopy.
Ned Flaxman, companion animal business unit director at Zoetis said: “Following an unprecedented demand for PropoFlo Plus, which we believe was caused by an out of stock situation from a competitor product, we have quickly ramped up production in order to return PropoFlo Plus to the market as quickly as possible. I am pleased to confirm that we now have sufficient stocks to supply the entire UK veterinary market for the foreseeable future”.
For further information, contact your Zoetis Account Manager.
Andrew, who graduated in 2002 from The University of Bristol, started as a farm vet in Devon and Cornwall, which is where he first became interested in cardiology.
He went on to undergo Specialist Training at The University of Edinburgh and then spent four years working in the pharmaceutical industry.
Andrew then spent almost two years as Head of Cardiology at a large referral hospital in Winchester, before leaving to co-found the first ever video consulting platform for pet owners, Pawsquad.
Since then, he has led teams in some of the largest specialist veterinary referral hospitals in Europe.
More recently, Andrew has run his own specialist-led visiting cardiology service, providing clinical consultancy services to 50 veterinary practices across the south of England for the last five years.
Andrew has been an EBVS European Veterinary Specialist in Small Animal Cardiology and a RCVS Recognised Specialist in Veterinary Cardiology for 10 years.
At Lumbry Park, Andrew plans to use his new role to provide specialist-led care to pets from across the South of England, and to provide cardiac clinical input for the multi-disciplinary team at Lumbry Park who manage patients with some of the most complex clinical problems in the country.
www.lumbrypark.co.uk
Norbrook Laboratories Ltd has launched Mycinor tablets (clindamycin), an antibiotic for treating soft tissue infections in dogs.
Rebekah Dudek, Norbrook Veterinary Advisor said: "Clindamycin is one of the leading prescription medicines used to treat soft tissue infections and offers very effective treatment particularly for dental and oral infections.
"Mycinor can be used to treat infected mouth cavities and oral infections and to provide antimicrobial cover prior to dental procedures such as tooth removal, scale & polish etc. Beyond dental expertise, Mycinor can also be used to treat soft tissue infections, skin infections in the form of superficial pyoderma and osteomyelitis bone infections. Mycinor is a fast acting antibiotic, rapidly absorbed into the body with effective levels within 30 minutes of administration."
Mycinor is available as 25mg, 75mg and 150mg in packs of 100tablets, and as a 300mg tablet in a pack of 150 tablets. Rebekah added: "Mycinor is a very effective and safe antibiotic and is ideal for long and short term treatments. It can be dosed once daily or at twice daily intervals if preferred."
For more information, visit www.norbrook.com
Elanco has announced that it has finalised its acquisition of Novartis Animal Health.
The acquisition, announced in April last year, follows Elanco's purchase of Lohmann Animal Health earlier in 2014. It swells Elanco's portfolio to nearly 300 brands encompassing therapeutics, vaccines, parasiticides, antimicrobials, surgical, enzymes, food safety and more.
Gaynor Hillier, Elanco's General Manager UK and Ireland said: "Elanco's acquisition of Novartis Animal Health brings together two strong companies with a passion for serving the customer. We will continue to offer the products our customers trust, while significantly investing in the development of new solutions to meet our customers' greatest unmet needs."
The company says it will now increase investment in research and development significantly, with a combined portfolio of more than 100 product development projects focused on:
Gaynor added: "We'll continually seek innovative ways we can support our customers' business. With increased technical services, that combine our analytic and benchmarking tools with on-the-ground support, we'll be able to spend more time with individual customers seeking innovative solutions that can make a difference in their business."
Elanco says that the complete integration of the businesses will take some time, but it is trying to make the transition seamless. For the foreseeable future, business will continue in much the same way, including product ordering and customer support. Availability and access to products will continue uninterrupted.
For more information about the acquisition, visit www.elanco.com.
Located in the South East of England, the centre is part of the new School of Veterinary Medicine at the University of Surrey, and one of the UK's largest veterinary pathology centres, offering high-containment post-mortem examination facilities and histopathology.
The centre is staffed by a team of board-certified veterinary pathologists, veterinary investigation officers and technicians, with expertise in farm-animal, equine, exotic and small-animal pathology.
The new building centres on a large containment level 2 post-mortem examination room with high ceilings, natural lighting, post-mortem examination tables, biological safety cabinets and integrated cold rooms, all served by a powerful winch system which means that post-mortem examinations can be performed on a wide range of species. A viewing gallery overlooks the suite and post-mortem examinations can be recorded and streamed for training purposes.
Professor Roberto La Ragione, Director of the Veterinary Pathology Centre, said: "Veterinary pathology is a growing discipline and its importance has been highlighted in recent disease outbreaks and the important role veterinary pathologists make in drug development. Helping the farming community to be more effective, sustainable and innovative, the Centre will work with partners, businesses and researchers to address some of the unique challenges faced by the veterinary and scientific community.
"It is the close relationships with our external clinical and scientific partners that enables us to be innovative in our approach to education and training here at the Surrey. An example of the latter is the use of digital pathology in teaching, research and diagnostics, which was the subject of discussion at the recent launch of the Veterinary Health Innovation Engine (vHive).
"Together with our partners such as the National Physical Laboratory and the 5G Innovation centre, the Centre is at the forefront of the digitalisation of pathology and innovative big data management.
"The Centre offers the opportunity to inspire the next generation of veterinary pathologists and complements the centres of excellence that already exist in other vet schools and research institutes."
The company says that by encouraging socialisation, natural behaviour and good health practices, the campaign will help puppy owners get their journey off to a good start and, with their vet, raise a dog that is healthy and family friendly.
The initiative comprises a range of practice materials, including health advice, training and behaviour tips, and a new owner video covering the essentials of puppy ownership.
The materials include digital content to use in email campaigns and on practice websites and social media channels.
Further support on how to optimise social media channels is also available to practices through PetNatter – Boehringer's free veterinary resource designed to help practices make the most of the opportunities social media provides.
Evelyn Murphy, senior brand manager for NexGard Spectra, said: “The ‘Relax, it’s a Puppy Thing’ initiative is a breath of fresh air and will provide puppy owners with just what they need to help them nurture a puppy through its formative life-stage, while easily and effectively supporting practices in communicating with owners on puppy health and welfare.”
For further information, contact your Boehringer Ingelheim territory manager.
Sanofi-aventis has signed an agreement under which it will buy Merck & Co Ltd's 50% stake in Merial Limited for $4 billion cash, after which it will own Merial outright.
According to the Wall Street Journal, Merck is selling its stake in Merial to avoid concerns from antitrust regulators that its pending acquisition of Schering-Plough will make it too dominant.
Merck, sanofi-aventis and Schering-Plough have also announced another agreement under which sanofi-aventis will have the option to combine Merck's Intervet/Schering-Plough Animal Health business with Merial to form an animal health joint venture owned equally by Merck and sanofi-aventis.
I thought Merial-Intervet-Schering-Plough was a bit of a mouthful, but sanofi-aventis-Merial-Intervet/Schering-Plough? The receptionist is going to have her work cut out.
Petsox Ltd has launched a new waterproof and breathable bandage cover.
According to the company, most products available to practices are either waterproof or breathable, but not both, and so cause the wound to overheat and the underlying skin to become "sweaty". Petsox, however, has a membrane system which allows the wound to breathe while providing protection from the elements.
Designed to go over the already cleaned and dressed wound, PetSox can be secured in place by attaching a length of cohesive bandage to the top. Petsox can also be trimmed to fit each animal perfectly.
Petsox have a non-slip base, so the animal can feel secure on slippery surfaces, such as wooden or tiled floors.
The company will be exhibiting at the London Vet Show this year on the Barber of Sheffield stand, where there will also be a competition with the chance to win lunch for 2 on the Orient Express.
For more information about Petsox, visit: www.petsox.co.uk